All news

Mangoceuticals clears new Series D preferred stock

Alpha Vantage · Investing.com UK · · AI-summarised by FinFlash

Mangoceuticals' board and its sole Series B Convertible Preferred Stockholder approved a new class of 8% Series D Convertible Cumulative Preferred Stock. The company can offer up to 1,000,000 shares at

Read original source

MGRX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.